Literature DB >> 6180734

Inhibition of murine leukaemia virus reverse transcriptase by 2-halogenated polyadenylic acids.

T Fukui, E De Clercq.   

Abstract

Several new analogues of polyadenylic acid [(A)n], i.e. poly(2-fluoroadenylic acid) [(fl2A)n], poly(2-chloroadenylic acid [(cl2A)n], poly(2-bromoadenylic acid) [(br2A)n] and poly(2-iodoadenylic acid) [(io2A)n] have been synthesized and evaluated for their effects on the RNA-directed DNA polymerase (reverse transcriptase) activity of Moloney murine leukaemia virus. All (A)n analogues were found to be potent inhibitors of reverse transcriptase, the order of (decreasing) potency being (fl2A)n greater than (io2A)n greater than (br2A)n greater than (cl2A)n. For all four (A)n analogues the inhibition of reverse transcriptase was competitive with respect to the template-primer. (A)n . oligo(dT). The K1 values were 0.02 microgram/ml for (fl2A)n, 0.1 microgram/ml for (io2A)n, 0.5 microgram/ml for (br2A)n and 8 microgram/ml for (cl2A)n. With a Ki of 0.02 microgram/ml (approx. 0.04 microM), (fl2A)n can be considered as one of the most, if not the most, potent polynucleotide inhibitor of reverse transcriptase that has been described so far.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180734      PMCID: PMC1158292          DOI: 10.1042/bj2030755

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Antiviral and antimetabolic activities of poly (7-deazaadenylic acid) and poly (7-deazainosinic acid).

Authors:  E de Clercq; A Billiau; P F Torrence; J A Waters; B Witkop
Journal:  Biochem Pharmacol       Date:  1975-12-15       Impact factor: 5.858

2.  Inhibition of synthesis of murine leukemia virus in cultured cells by polyribonucleotides and their 2'-O-alkyl derivatives.

Authors:  S K Arya; W A Carter; J L Alderfer; P O Ts'o
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

3.  The inhibition of avian myeloblastosis virus deoxyribonucleic acid polymerase by synthetic polynucleotides.

Authors:  R J Erickson; J C Grosch
Journal:  Biochemistry       Date:  1974-04-23       Impact factor: 3.162

4.  Inhibition of RNA directed DNA polymerase of murine leukemia virus by 2'-O-alkylated polyadenylic acids.

Authors:  S K Arya; W A Carter; J L Alderfer; P O Ts'o
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

5.  Effects of polyadenylic acids on functions of murine RNA tumor viruses.

Authors:  R W Tennant; J G Farrelly; J N Ihle; B C Pal; F T Kenney; A Brown
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

6.  Effects of poly(2'-O-methyladenylic acid) on susceptibility and autogenous immunity to RNA tumor virus oncogenesis in vivo.

Authors:  R W Tennant; M G Hanna; J G Farrelly
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

7.  Poly (2'O-methylcytidylate).oligodeoxyguanylate, a template-primer specific for reverse transcriptase, is not utilized by HeLa cell gamma DNA polymerases.

Authors:  G F Gerard
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

8.  Inhibition of oncornavirus functions by 2'-azido polynucleotides.

Authors:  E De Clercq; A Billiau; J Hobbs; P F Torrence; B Witkop
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Role of purine N-3 in the biologic activities of poly(A) and poly(I).

Authors:  E de Clercq; P F Torrence; T Fukui; M Ikehara
Journal:  Nucleic Acids Res       Date:  1976-06       Impact factor: 16.971

10.  CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES.

Authors:  D E HOARD; D G OTT
Journal:  J Am Chem Soc       Date:  1965-04-20       Impact factor: 15.419

View more
  1 in total

1.  Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica.

Authors:  H Nakashima; Y Kido; N Kobayashi; Y Motoki; M Neushul; N Yamamoto
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.